How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Allergen Kit Market
- By Product Type: Food Allergen Test Kits, Environmental Allergen Test Kits, Pharmaceutical Allergen Test Kits, Cosmetic Allergen Test Kits, Pet Allergen Test Kits
- By Technology: Enzyme-Linked Immunosorbent Assay (ELISA) Kits, Lateral Flow Assay (LFA) Kits, Polymerase Chain Reaction (PCR) Kits, Immunoassay Kits, Biosensor-Based Kits
- By End User: Clinical Diagnostic Laboratories, Research Laboratories, Food Industry, Pharmaceutical Industry, Environmental Testing Laboratories
- By Application: Food Safety Testing, Clinical Allergy Diagnosis, Environmental Allergen Monitoring, Pharmaceutical Quality Control, Cosmetic Product Testing
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Food Allergen Test Kits leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 284 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.170 →
- 11 Company Profiles 16 players: SWOT & benchmarking p.178 →
Full report · locked preview
Everything inside the Allergen Kit Market report
A complete, evidence-based study - 11 chapters and 119 sections covering market size, segmentation across 4 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Technology 5
End User 5
Application 5
Companies profiled
Thermo Fisher Scientific
Abbott Laboratories
Bio-Rad Laboratories
R-Biopharm AG
Neogen Corporation
ELISA Technologies Inc.
Hycult Biotech
Allersearch Allergy Testing
Omega Diagnostics Group PLC
Indoor Biotechnologies
ImmunoCAP (Phadia
part of Thermo Fisher Scientific)
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Abbott Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Bio-Rad Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →R-Biopharm AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Neogen Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →ELISA Technologies Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Hycult Biotech
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Allersearch Allergy Testing
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Omega Diagnostics Group PLC
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Indoor Biotechnologies
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →ImmunoCAP (Phadia
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →part of Thermo Fisher Scientific)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Inmunotek S.L.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Allergy Therapeutics plc
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Hollister-Stier Laboratories
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Alk-Abelló A/S
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$5,286M by 2033 · 4.0% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Food Allergen Test Kits48.5
- Environmental Allergen Test Kits14.6
- Pharmaceutical Allergen Test Kits13.7
- Cosmetic Allergen Test Kits14.4
- Pet Allergen Test Kits8.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,270M → $1,676M · 3.5%
Europe$885.2M → $1,251M · 4.4%
Asia Pacific$808.2M → $1,221M · 5.3%
Latin America$500.3M → $739.5M · 5.0%
Middle East and Africa$384.9M → $472.7M · 2.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →4.002026
4.022027
4.012028
4.022029
4.042030
4.052031
4.062032
4.082033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Thermo Fisher Scientific20.7
- Abbott Laboratories15.9
- Bio-Rad Laboratories8.4
- R-Biopharm AG11.1
- Neogen Corporation12.1
- ELISA Technologies Inc.3.9
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type28.8%
Technology29.6%
End User15.9%
Application25.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.3
- Europe23.3
- Asia Pacific22.8
- Latin America13.8
- Middle East and Africa8.8
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | 89 | 76 | 77 | 91 | 86 | 98 | 86 |
| Abbott Laboratories | 76 | 86 | 73 | 73 | 91 | 89 | 81 |
| Bio-Rad Laboratories | 62 | 66 | 80 | 75 | 75 | 80 | 73 |
| R-Biopharm AG | 66 | 69 | 76 | 78 | 61 | 58 | 68 |
| Neogen Corporation | 64 | 71 | 76 | 53 | 54 | 66 | 64 |
| ELISA Technologies Inc. | 70 | 52 | 53 | 62 | 61 | 49 | 58 |
| Hycult Biotech | 53 | 59 | 55 | 58 | 62 | 64 | 59 |
| Allersearch Allergy Testing | 49 | 46 | 35 | 57 | 49 | 41 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Thermo Fisher Scientific
- Abbott Laboratories
- Bio-Rad Laboratories
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Thermo Fisher Scientific | ◐ | ✓ | ◐ | ◐ | ✓ | ✓ |
| Abbott Laboratories | ◐ | ✓ | ✓ | ◐ | ◐ | ✓ |
| Bio-Rad Laboratories | − | ◐ | ✓ | ✓ | ◐ | ◐ |
| R-Biopharm AG | ◐ | − | ◐ | ✓ | ◐ | − |
| Neogen Corporation | − | ◐ | ✓ | − | − | − |
| ELISA Technologies Inc. | − | − | − | ◐ | ◐ | − |
| Hycult Biotech | ◐ | − | − | ◐ | ◐ | − |
| Allersearch Allergy Testing | ◐ | ◐ | − | ◐ | ◐ | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Thermo Fisher Scientific86
2Abbott Laboratories81
3Bio-Rad Laboratories73
4R-Biopharm AG68
5Neogen Corporation64
6Hycult Biotech59
7ELISA Technologies Inc.58
8Allersearch Allergy Testing46
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Thermo Fisher ScientificAbbott Laboratories
Challenger2
Strong scale, closing on the leaders.
Bio-Rad LaboratoriesR-Biopharm AG
Contender3
Focused players with pockets of strength.
Neogen CorporationELISA Technologies Inc.Hycult Biotech
Niche1
Specialists in a single segment or region.
Allersearch Allergy Testing
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Allergen Kit Market — a $158M beachhead inside a $2.39B market.
Beachhead (SOM)$158Mobtainable near-term
Serviceable (SAM)$946Mreachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Food Allergen Test Kits
Best fit — highest urgency & budget in Product Type.
Economic buyer80 fit
Environmental Allergen Test Kits
Strong fit — clear ROI and a fast path to value.
End user66 fit
Pharmaceutical Allergen Test Kits
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Technology & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel30%
Digital / self-serve19%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Allergen Kit Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified23%
Evaluation12%
Closed-won7%
$8.7KCAC
$50KLTV
5.7:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Allergen Kit Market is a durable-growth opportunity — $3.90B by 2033, compounding at 7.8%.
TAM · 2025$2.14Btoday
TAM · 2033$3.90Bforecast
CAGR7.8%2027–2033
Cumulative$26.5Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$3.90BTotal addressable market
SAM$1.49BServiceable available market
SOM$306MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.8% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$3.90BLarge & growingTAM by 2033 at 7.8% CAGR
$1.49BServiceable nowreachable with today’s model
$306MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.04BBear5.1% CAGR
$3.90BBase7.8% CAGR
$4.99BBull10.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Technology optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Allergen Kit Market — a $5.44B market by 2033. Plan: grow share from 7.7% to 15.3%.
Market size · 2033$5.44Btotal addressable
Market CAGR11.3%2027–2033
Target share15.3%from 7.7% today
Revenue ambition$832Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.7% | 15.3% | At risk |
| Revenue | $392M | $832M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | Behind |
| Gross margin | 33.3% | 39.1% | On track |
| Customer retention | 87.3% | 94.7% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Technology capability
A defensible second engine — invest in Technology to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Technology
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $114M capacity & capability investment
- Greenlight bolt-on M&A in Technology
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAhead
- Input-cost & supply riskAt risk
- Regulatory / policy changeBehind
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Allergen Kit Market conversation — a $7.97B market you can size, segment and defend in minutes.
Market size · 2033$7.97Btotal opportunity
Growth8.1%CAGR to 2033
Addressable buyers1,682+accounts in scope
Typical ROI6×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6×return on cost, year one
< 3 mopayback period
$91K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Thermo Fisher ScientificAbbott LaboratoriesBio-Rad LaboratoriesR-Biopharm AGNeogen CorporationELISA Technologies Inc.Hycult BiotechAllersearch Allergy Testing+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Allergen Kit Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Allergen Kit Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Phosphodiesterase Type 5 (PDE5) Inhibitor Market
Market size, share, segmentation and regional forecast.
$2.3B market · 2025 base year
View reportPhosphodiesterase (PDE) inhibitors Market
Market size, share, segmentation and regional forecast.
$2.6B market · 2025 base year
View reportAllergen Extract Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportPhosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market
Market size, share, segmentation and regional forecast.
$992M market · 2025 base year
View reportAllergen Diagnostic Tests Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportAllergen Detection Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportPerennial Allergic Rhinitis Drug Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportAllergen Detection Kit Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportPeptide Receptor Radionuclide Therapy (PRRT) Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportAllergen Clinical Testing Kits Market
Market size, share, segmentation and regional forecast.
$1.0B market · 2025 base year
View reportPeptide APIs Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportPeptide and Anticoagulant Drugs Market
Market size, share, segmentation and regional forecast.
$410M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.